Abnormal cannabidiol
Synthetic cannabinoid compound
Abnormal cannabidiol (abn-CBD) is a synthetic compound that is structurally related to cannabidiol (CBD), a naturally occurring constituent of the Cannabis plant. Unlike CBD, abn-CBD does not bind to the classical cannabinoid receptors, such as CB1 and CB2, but it has been shown to interact with other targets in the body, including the GPR55 receptor and the TRPV2 channel.
Chemical structure[edit | edit source]
Abnormal cannabidiol is a cannabinoid derivative with a unique structure that distinguishes it from other cannabinoids. The chemical structure of abn-CBD is characterized by the presence of a cyclohexene ring and a pentyl side chain, similar to CBD, but with a different configuration of the hydroxyl groups and the cyclohexene ring.
Pharmacology[edit | edit source]
Abnormal cannabidiol has been studied for its potential pharmacological effects, which differ from those of traditional cannabinoids. It does not activate the CB1 or CB2 receptors, which are the primary targets of most cannabinoids. Instead, abn-CBD has been shown to act as an agonist at the GPR55 receptor, a receptor that is involved in various physiological processes, including pain perception and inflammation.
Additionally, abn-CBD has been found to activate the TRPV2 channel, a member of the transient receptor potential channel family, which is involved in the detection of temperature and pain.
Potential therapeutic applications[edit | edit source]
Research into abnormal cannabidiol has suggested potential therapeutic applications, particularly in the areas of pain management and neuroprotection. Its ability to modulate GPR55 and TRPV2 channels may offer new avenues for the development of treatments for conditions such as chronic pain, inflammatory diseases, and neurological disorders.
Related compounds[edit | edit source]
Abnormal cannabidiol is part of a broader class of synthetic cannabinoids that are being investigated for their unique properties and potential medical benefits. Other related compounds include:
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Cannabigerol (CBG)
See also[edit | edit source]
Gallery[edit | edit source]
3D ball-and-stick model of abnormal cannabidiol
Abnormal_cannabidiol[edit | edit source]
3D ball-and-stick model of Abnormal cannabidiol
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD